Senior prescription drug costs could hit $1.8 trillion over next 10 years,meaning benefit covering half would entail spending some $900 billion
Seemal Desai, MD, Responds to Study Suggesting Melanoma is Overdiagnosed in White Patients
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Facial Skin Cancer Surgery Yields Low and Improved Scores For Perceived Stigmatization, Body Image Concerns, and Psychosocial Distress
ReV Up Your Vitiligo Treatment Strategies
Ruxolitinib, Educational Initiatives for Managed Care Professionals Play Crucial Role in Optimizing Care in Atopic Dermatitis
ASLAN Announces Positive Phase 2 Results of Eblasakimab in Dupilumab-Treated Patients With AD